Newsroom

GOOD
NEWS

The next technical revolution is here. We use synthetic biology to remake the world’s chemistry and are making a positive impact – for businesses and bottom lines. For the health of people. And for the planet.

We apply inspired science to deliver inspired
solutions for a more sustainable world.

LEARN MORE ABOUT OUR NO COMPROMISE® PLEDGE
Media Kit

Our media kit contains multimedia content for you to download.
You can also contact us directly at: [email protected]

Download Media Kit Download Media Kit

Blog

Latest Articles Latest Articles
Latest Articles Latest Articles

PRESS RELEASES

Amyris Consolidates R&D Operations in the U.S. and Brazil and Exits Portugal

Amyris Consolidates R&D Operations in the U.S. and Brazil and Exits Portugal

Following the completion of a strategic review of its global R&D operations and business model, the company has made the decision to consolidate its R&D footprint in the U.S. and Brazil.

Learn More

AMYRIS ANNOUNCES APPROVAL AND FUNDING OF 2030 STRATEGIC PLAN

AMYRIS ANNOUNCES APPROVAL AND FUNDING OF 2030 STRATEGIC PLAN

The company’s 2030 Strategic Plan has been approved by its Board of Directors.

Learn More

AMYRIS AWARDED AGREEMENT FROM BIOMAP-CONSORTIUM TO DEVELOP CRITICAL MEDICINES TO SUPPORT RESILIENT DOMESTIC SUPPLY GOALS

AMYRIS AWARDED AGREEMENT FROM BIOMAP-CONSORTIUM TO DEVELOP CRITICAL MEDICINES TO SUPPORT RESILIENT DOMESTIC SUPPLY GOALS

Amyris aims to develop up to three small molecule drugs over the next two years – all of which are on the FDA drug shortage list.

Learn More

AMYRIS ANNOUNCES KATHY FORTMANN AS NEW CEO

AMYRIS ANNOUNCES KATHY FORTMANN AS NEW CEO

Amyris has appointed Kathy L. Fortmann as Chief Executive Officer effective immediately.

Learn More

Loading data...